doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. A08/322
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5477 |
---|---|
E‑mail: |
Total number of publications: 152
2017
-
Diastereoselective Flexible Synthesis of Carbocyclic C Nucleosides
The Journal of Organic Chemistry, year: 2017, volume: 82, edition: 7, DOI
-
Direct nanopatterning of biomolecules by electron beam lithography for studying of cellular interaction
Year: 2017, type: Conference abstract
-
Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines
European Journal of Medicinal Chemistry, year: 2017, volume: 126, edition: January, DOI
-
Flow cytometric analysis of nucleoside transporters activity
Year: 2017, type: Conference abstract
-
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Neoplasia, year: 2017, volume: 19, edition: 10, DOI
-
INHIBITION OF CHK1 STIMULATES THE COOPERATIVE CYTOTOXIC ACTION OF PLATINUM-BASED DRUGS AND TRAIL IN HUMAN PROSTATE CANCER CELLS
Year: 2017, type: Conference abstract
-
Kompletní analýza vlastností nových inhibitorů kasein kinázy 1 pro léčbu chronické lymfocytární leukémie
Year: 2017, type:
-
Pyrazolotriazines as inhibitors of nucleases
Publisher: European Patent Office, state: Germany, patent's number: EP2957562, year: 2017
-
Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles
ChemPhysChem, year: 2017, volume: 18, edition: 7, DOI
-
Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation
Molecular Cancer Therapeutics, year: 2017, volume: 16, edition: 9, DOI